• Publications
  • Influence
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients
PurposeImatinib mesylate is presently the first-line treatment for chronic myeloid leukemia (CML). Therapeutic drug monitoring (TDM) and pharmacogenetic screening is warranted for better managementExpand
  • 12
  • 3
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib
Abstract Imatinib mesylate is currently considered the first-line treatment for chronic myeloid leukemia (CML). Sokal, Hasford and EUTOS are the three major risk categorization scores available forExpand
  • 15
  • 2
Functional outcome of tibial condyle fractures following open reduction and internal fixation with plate and screws
Aims and objectives To evaluate the functional outcome of tibial plateau fractures treated by open reduction and internal fixation with buttress plating. Materials and methods 25 patients with tibialExpand
  • 2
  • 1
Correlation between MRI and arthroscopic findings in injuries of knee joint
injuries and its various types with arthroscopy, to find out the specificity, sensitivity, positive and negative predictive values of MRI in diagnosing different injuries, to know the role ofExpand
  • 3
  • 1
Antibiotic cement impregnated nailing in the management of infected non-union of femur and tibia
Infected non-union of long bones present a complex problem to the treating surgeon. The treatment of non-union follows traditionally followed a two staged procedure. More recently, single stageExpand
  • 10
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine
Rifapentine is a rifamycin used to treat tuberculosis. As is the case for rifampin, plasma exposures of rifapentine are associated with the treatment response. ABSTRACT Rifapentine is a rifamycinExpand
  • 4
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study
Objective: To monitor the adverse drug reactions (ADRs) associated with imatinib treatment in patients with chronic myeloid leukemia (CML) in a tertiary care hospital. Materials and Methods: TheExpand
  • 5
Correlation of MRI with arthroscopy in injuries of knee joint
Aims and objectives Arthroscopy has remained the reference standard for the diagnosis of internal derangements of the knee, against which alternative diagnostic modalities should be compared. In thisExpand
  • 3
A study to explore the correlation of trough level concentration and ABCB1, OCT1, ABCG2 genetic polymorphisms with imatinib mesylate induced thrombocytopenia in chronic myeloid leukemia patients.
e13564 Background: Imatinib mesylate is presently the first line treatment for chronic myeloid leukemia (CML). Therapeutic drug monitoring (TDM) and pharmacogenetic screening is warranted for bette...